UNSPSC 51284029: Doxycycline hydrochloride hemiethanolate hemihydrate

This classification denotes a tetracycline antibiotic with the molecular formula 2C22H24N2O8.C2H6O.2ClH.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 19XTS3T51U, chemically known as 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride, compound with ethyl alcohol (2:1), monohydrate, but more generally known as doxycycline hydrochloride hemiethanolate hemihydrate, which bears US NIH Compound Identifier 5282244.

UNSPSC 51284029 Doxycycline hydrochloride hemiethanolate hemihydrate, a Commodity code, shows minimal recent state and local procurement activity directly aligned with the pharmaceutical product itself; the recent opportunities tagged to this code instead reflect broader pharmaceutical procurement, emergency medical supplies, and pharmacy benefit program initiatives that do not specifically target doxycycline or related tetracycline-class antibiotics.

The recent solicitations under this code span emergency medical supply procurement, generic pharmaceutical distribution contracts, and pharmacy benefit innovation initiatives. The City of Tampa's Fire Department Rescue Division issued IFB 26P00145 in March 2026 for medical and first aid supplies ($700,000 estimated value), with a response deadline of March 13, 2026, designated as a sheltered market for certified Small Local Business Enterprises with a 5% bid discount. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products, with proposals due March 26, 2026, requiring distribution through AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co., LLC, with contract effectiveness July 1, 2026. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, to gather vendor information on direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager arrangements. Issuing bodies include municipal fire departments, state cooperative purchasing alliances, county health departments, and state health and human services agencies. Geographic concentration appears in Florida (Seminole County), Texas, Minnesota (with multistate reach including Oregon), and California. The mismatch between the code's nominal focus on doxycycline and the actual opportunities suggests this code is not a reliable indicator of demand for this specific pharmaceutical; procurement professionals evaluating doxycycline supply contracts should monitor broader generic pharmaceutical and emergency medical supply solicitations rather than rely on this code's recent activity.